| Genetics insight for COVID-19 susceptibility and severity: a review I Fricke-Galindo, R Falfán-Valencia Frontiers in immunology 12, 622176, 2021 | 174 | 2021 |
| Interethnic variation of CYP2C19 alleles,‘predicted’phenotypes and ‘measured’metabolic phenotypes across world populations I Fricke-Galindo, C Céspedes-Garro, F Rodrigues-Soares, MEG Naranjo, ... The pharmacogenomics journal 16 (2), 113-123, 2016 | 163 | 2016 |
| Carbamazepine adverse drug reactions I Fricke-Galindo, A LLerena, H Jung-Cook, M López-López Expert review of clinical pharmacology 11 (7), 705-718, 2018 | 89 | 2018 |
| Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes C Céspedes-Garro, I Fricke-Galindo, MEG Naranjo, F Rodrigues-Soares, ... Expert opinion on drug metabolism & toxicology 11 (12), 1893-1905, 2015 | 67 | 2015 |
| HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients I Fricke-Galindo, IE Martínez-Juárez, N Monroy-Jaramillo, H Jung-Cook, ... Pharmacogenomics 15 (15), 1881-1891, 2014 | 55 | 2014 |
| Pharmacogenetics of adverse reactions to antiepileptic drugs I Fricke-Galindo, H Jung-Cook, A LLerena, M López-López Neurología (English Edition) 33 (3), 165-176, 2018 | 51 | 2018 |
| Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality Y Palacios, A Ruiz, LA Ramón-Luing, R Ocaña-Guzman, ... International journal of molecular sciences 22 (16), 8423, 2021 | 41 | 2021 |
| Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF … MEG Naranjo, F Rodrigues-Soares, EM Penas-Lledo, E Tarazona-Santos, ... Omics: a journal of integrative biology 22 (9), 575-588, 2018 | 40 | 2018 |
| An update on HLA alleles associated with adverse drug reactions I Fricke-Galindo, A LLerena, M López-López Drug Metabolism and Personalized Therapy 32 (2), 73-87, 2017 | 36 | 2017 |
| CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy A Ortega-Vázquez, P Dorado, I Fricke-Galindo, H Jung-Cook, ... The Pharmacogenomics Journal 16 (3), 286-292, 2016 | 36 | 2016 |
| Farmacogenética de reacciones adversas a fármacos antiepilépticos I Fricke-Galindo, H Jung-Cook, A Llerena, M López-López Neurología 33 (3), 165-176, 2018 | 29 | 2018 |
| IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19 I Fricke-Galindo, A Martínez-Morales, L Chávez-Galán, R Ocaña-Guzmán, ... Frontiers in Immunology 13, 949413, 2022 | 27 | 2022 |
| Pharmacogenetics approach for the improvement of COVID-19 treatment I Fricke-Galindo, R Falfán-Valencia Viruses 13 (3), 413, 2021 | 27 | 2021 |
| Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics) I Fricke-Galindo, H Jung-Cook, A LLerena, M López-López Drug Metabolism and Personalized Therapy 31 (2), 61-81, 2016 | 19 | 2016 |
| Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response NM Jaramillo, IF Galindo, AO Vázquez, HJ Cook, A LLerena, ML López Drug metabolism and drug interactions 29 (2), 67-79, 2014 | 19 | 2014 |
| Pharmacogenetic studies in Alzheimer disease TZ Santamaría, PY Gómez, IF Galindo, MG González, AO Vázquez, ... Neurología (English Edition) 37 (4), 287-303, 2022 | 16 | 2022 |
| TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19 I Fricke-Galindo, I Buendía-Roldán, A Ruiz, Y Palacios, G Pérez-Rubio, ... The Journal of Infectious Diseases 226 (5), 778-787, 2022 | 13 | 2022 |
| Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms AF Favela-Mendoza, H Rangel-Villalobos, I Fricke-Galindo, ... Molecular biology reports 45, 2525-2533, 2018 | 12 | 2018 |
| Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population IA Gutiérrez-Pérez, I Buendía-Roldán, G Pérez-Rubio, L Chávez-Galán, ... Frontiers in Medicine 9, 1000147, 2022 | 11 | 2022 |
| SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital I Fricke-Galindo, I Buendia-Roldan, L Chavez-Galan, G Pérez-Rubio, ... Biology 11 (4), 595, 2022 | 10 | 2022 |
Ramcés Falfán-ValenciaInstituto Nacional de Enfermedades Respiratorias Ismael Cosio VillegasVerified email at iner.gob.mx
